Clinical Trial Update: NOGO for an Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NOGO targeting overactive bladder and nocturia; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia
• Overactive Bladder

Drugs mentioned

• NOGO

Snippet

Sponsor: SagaNatura | Conditions: Overactive Bladder, Nocturia | Phase 2 | Status: UNKNOWN